[PR Newswire] - SAN DIEGO, Dec. 2, 2013 /PRNewswire/ -- Trovagene, Inc.
(NASDAQ: TROV), a developer of cell-free molecular diagnostics, today
announced that Chief Executive Officer Antonius Schuh, Ph.D. is scheduled to
present a corporate overview at the Piper Jaffray 25th Annual Healthcare
Conference. Trovagene is scheduled to present at the Piper Jaffray 25th Annual
Healthcare Conference at the Palace Hotel in New York, NY on Wednesday,
December 4, 2013 at 3:30 p.m. Mr. Schuh will be available for one-on-one
meetings during the conference. The presentation will be webcast live at
http://www.media-server.com/m/p/ht25xx3q and can also be accessed through the
investor relations page at www.trovagene.com.